by: Clinical Trials of Texas, Inc.
A small match-stick sized device implanted under the skin could be a revolutionary new treatment for those with diabetes.
“We are seeing very promising results with this new device,” says Dr. Douglas Denham, principle investigator and medical director at Clinical Trials of Texas.
Denham says that the tiny device is implanted under the skin of the abdomen and slowly releases a continuous dose of the diabetes medication, exanatide, for up to 1 year.
“The device is implanted in a procedure that takes just about five minutes,” says Denham. “It is an efficient new way to deliver diabetic medication and is a great alternative to needles and oral medications.”
Today, over 25 million people in the United States are thought to be diabetic. Dr. Denham and his colleagues say that diabetes is linked to all kinds of other ailments including blindness, heart attack and stroke.
The incidence of diabetes is rising so fast that researchers estimate that within a few years, it will account for one-tenth of the country’s healthcare bills.
“Diabetes is a growing problem and one that we need to get under control quickly,” says Denham.“Education on the causes of diabetes and helping those already diagnosed get their condition controlled will be key.”
Denham says that this new device, currently in Phase 3 research, will most likely be FDA approved in the next few years.
To learn more about this device, contact Clinical Trials of Texas at 210.949.0122 or visit our website.